Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics.
Revelli A, Delle Piane L, Casano S, Molinari E, Massobrio M, Rinaudo P. · 2009
Read Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics. by Revelli A, Delle Piane L, Casano S, Molinari E, Massobrio M, Rinaudo P. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2685803.txt.
Introduction
Revelli and colleagues reviewed in 2009 the search for chemical signs in follicular fluid that reveal how good a human egg is. In IVF, fertility treatment in a lab dish, doctors would love to pick the best eggs before fertilizing them. The fluid bathing each egg in the ovary is easy to collect during egg retrieval, making it a tempting place to look for clues.
Study after study had tested single molecules in the fluid: hormones, growth factors, sugars, and more. None proved reliable enough to judge an egg's power to fertilize, grow into an embryo, and start a pregnancy. The review then turns to metabolomics, the young approach of reading all small chemicals in the fluid at once. Patterns across many molecules may succeed where single markers failed. That work, the authors note, has only just begun.
Catalog record
| CREATOR | Revelli A, Delle Piane L, Casano S, Molinari E, Massobrio M, Rinaudo P. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 80 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics By Alberto Revelli, Luisa Delle Piane, Simona Casano, Emanuela Molinari, Marco Massobrio, Paolo Rinaudo Published in: Reproductive Biology and Endocrinology : RB&E DOI: 10.1186/1477-7827-7-40 ABSTRACT Abstract The assessment of oocyte quality in human in vitro fertilization (IVF) is getting increasing attention from embryologists. Oocyte selection and the identification of the best oocytes, in fact, would help to limit embryo overproduction and to improve the results of oocyte cryostorage programs. Follicular fluid (FF) is easily available during oocyte pick-up and theorically represents an optimal source on non-invasive biochemical predictors of oocyte quality. Unfortunately, however, the studies aiming to find a good molecular predictor of oocyte quality in FF were not able to identify substances that could be used as reliable markers of oocyte competence to fertilization, embryo development and pregnancy. In the last years, a well definite trend toward passing from the research of single molecular markers to more complex techniques that study all metabolites of FF has been observed. The metabolomic approach is a powerful tool to study biochemical predictors of oocyte quality in FF, but its application in this area is still at the beginning. This review provides an overview of the current knowledge about the biochemical predictors of oocyte quality in FF, describing both the results coming from studies on single biochemical markers and those deriving from the most recent studies of metabolomics BACKGROUND The assessment of oocyte quality is rapidly becoming one of the major objectives of embryologists in human in-vitro fertilization (IVF). In fact, although classical IVF does not include any process of oocyte selection and only embryos (sometimes zygotes) undergo selection, the general trend toward limiting embryo "overproduction" and the rapidly improving results of oocyte cryostorage, together with the restrictive legal rules introduced in some Countries, have challenged embryologists to identify criteria to select, among all oocytes retrieved, the best oocytes to inseminate. Multiple methods of oocyte selection have been proposed. The study of oocyte morphology is very popular, being relatively quick and simple; however, it leads to identify more frequently "negative" than "positive" predictors of oocyte quality, and overall is not fully satisfactory (for a comprehensive review: [1]). The same concepts may be applied to studies on polarizing microscopy analysis (for a review: []. Some authors have studied the expression of genes in the granulosa cells or in the oocyte itself, looking for specific molecular markers of oocyte quality (see the review [2]). Polar body biopsy is somewhere used to screen oocytes with chromosomal defects deriving from errors in the two meiotic divisions (see the review [3]). Most of these techniques are quite complicated, require expensive laboratory equipment and time-consuming procedures, and consequently are not currently applicable in the clinical practice. Follicular fluid (FF) provides a very important microenvironment for the development of oocytes. FF is a product of both the transfer of blood plasma constituents that cross the blood follicular barrier and of the secretory activity of granulosa and thecal cells [4]. It is reasonable to think that some biochemical characteristics of the FF surrounding the oocyte may play a critical role in determining oocyte quality and the subsequent potential to achieve fertilization and embryo development. The analysis of FF components may also provide information on metabolic changes in blood serum, as the circulating biochemical milieu may be reflected in the composition of FF [5]. FF is easily available as it is aspirated together with the oocyte at the time of OPU. In the last years, the study of FF content has been conducted by assaying one or more substances in the fluid derived from individual follicles and by relating it (them) to the fate of the egg coming from that specific follicle. For study purposes, in order to correlate FF substances with oocyte quality, it is imperative that each individual follicle is aspirated individually. The procedure of separated, single follicle aspiration is uncomfortable both for the patient and for the physician because multiple vaginal punctures are required, with increased risk of vaginal bleeding and increased patient discomfort. Moreover, needle flushing with culture medium after every follicular puncture has to be performed in order to be sure that the oocyte is effectively retrieved from each specific follicle; flushing must be made with standard volumes of buffered solution in order to obtain a known dilution of FF substances. Another relevant problem in studies estimating oocyte quality in relation to FF composition is that oocyte nuclear maturity is assessed shortly after oocyte recovery only during ICSI cases. Oocyte maturity in IVF is usually assessed only the following day, and a mature oocyte could have completed the nuclear maturation when cultured. This could bias the results. Finally, it is not completely clear if the FF concentration of a given substance is a variable related to the quality of the follicle (and therefore possibly reflecting the quality of the oocyte inside it) or to the clinical characteristics of the patient, such as age, smoking habit or type of ovarian stimulation. Overall, a clear correspondence between specific FF biochemical characteristics and measurable oocyte quality-linked, embryo-related variables has not been established to date. In the last years, the research in this area has progressed toward a more complex type of molecular analysis, metabolomics, that is the analysis of all substances contained in a biological fluid. This review provides an overview of the current knowledge about the biochemical predictors of oocyte quality in FF, describing both the results coming from studies on single biochemical markers and those deriving from the most recent studies of metabolomics. The chemical constituents of FF have been grouped in the following categories: a) hormones; b) growth factors of the Transforming Growth Factor-beta (TGF-beta) superfamily; c) other growth factors and interleukins; d) Reactive Oxygen Species (ROS); e) anti-apoptotic factors; f) proteins, peptides and amino-acids; g) sugars; h) prostanoids. Hormones Gonadotropins Intrafollicular concentrations of FSH and LH are affected by their circulating levels: in IVF cycles the serum levels are determined by the amount of exogenously administered gonadotropins and by the degree of pituitary suppression (relevantly reducing the endogenous gonadotropin secretion). High FF concentrations of FSH [6], hCG [7], and LH [8] have been reported to promote oocyte maturation and to be associated with eggs having a high chance of fertilization. These findings are confirmed by immunohistochemistry studies that stained granulosa cells for hCG: oocytes that subsequently fertilized had, in fact, significantly more granulosa cells immunobound to hCG than non-fertilizable oocytes [9]. FF LH was observed to be consistently higher in follicles containing oocytes that resulted in embryos leading to successful IVF attempts [10]. It appears that gonadotropins play an important role in the secretion of several substances by granulosa cells (e.g. hyaluronic acid), in turn affecting oocyte development and maturation. They may also act synergistically with estradiol (E2) in enhancing cytoplasmic maturation of the egg and, via cyclic AMP (cAMP) secretion, control oocyte meiosis: higher levels of gonadotropins would improve these processes and lead to better oocytes, better embryos and improved pregnancy rate. Notably, GH seems to play a similar (and may be synergic with gonadotropins) role [10]. Growth hormone (GH) GH is known to enhance the FSH-dependent E2 production by granulosa cells [11]